Last reviewed · How we verify

NCT03541967

Comparison of a New Bone Conduction Hearing System to a Osteo-integrated Bone Conduction Hearing Aid on a Softband

Withdrawn NA Last updated 20 June 2019
What this trial tests

NA trial testing ADHEAR and PONTO 3 SUPER POWER on softband hearing aids in Conductive Hearing Loss. Withdrawn.

Timeline
15 July 2018
Primary endpoint
15 July 2019
15 July 2019

Quick facts

Lead sponsorMED-EL Elektromedizinische Geräte GesmbH
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposeother
Start date15 July 2018
Primary completion15 July 2019
Estimated completion15 July 2019

Drugs / interventions tested

Conditions studied

Sponsor

MED-EL Elektromedizinische Geräte GesmbH — full company profile →

Who can join

Adults 5 to 15, any sex, with Conductive Hearing Loss. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Main objectives * The first main objective is to evaluate the non-inferiority of the ADHEAR system compared to the PONTO 3 SUPERPOWER softband system in terms of average tonal gain. * The second main objective of the study is to evaluate the superiority of the ADHEAR system compared to the PONTO 3 SUPERPOWER softband system in terms of comfort. Secondary objectives * Evaluate skin reactions with ADHEAR and PONTO 3 SUPER POWER on softband. * Evaluate and compare perception in silence and noise with ADHEAR and PONTO 3 SUPER POWER on softband. * Evaluate and compare the subjective auditory perception with ADHEAR and PONTO 3 SUPER POWER on softband. * Evaluate the satisfaction and use of ADHEAR.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other MED-EL Elektromedizinische Geräte GesmbH trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03541967.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing